MedTrace Logo

Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD

NCT02173561 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-03-27

No results posted yet for this study

Summary

The purpose of this study is to conduct a randomized controlled trial to compare group and individual CPT-C for the treatment of PTSD in OIF/OEF military personnel.

Conditions

Interventions

BEHAVIORAL

Group Cognitive Processing Therapy-Cognitive Only

Cognitive Processing Therapy-Cognitive Only version (CPT-C) is an evidence-based form of Cognitive Behavioral Therapy (CBT) used to treat PTSD. CPT-C is a 12-session manualized program that focuses on challenging beliefs and assumptions related to the trauma, oneself, and the world. Sessions will be conducted in groups of 8-12 participants. Sessions will be conducted twice weekly for six weeks; each session is 90 minutes.

BEHAVIORAL

Individual Cognitive Processing Therapy-Cognitive Only

Cognitive Processing Therapy-Cognitive Only (CPT-C) is an evidence-based form of Cognitive Behavioral Therapy (CBT) used to treat PTSD. CPT is a 12-session manualized program that focuses on challenging beliefs and assumptions related to the trauma, oneself, and the world. Individual sessions will be conducted twice weekly for six weeks; each session is 60 minutes.

Sponsors & Collaborators

  • VA Boston Healthcare System

    collaborator FED

  • The University of Texas Health Science Center at San Antonio

    collaborator OTHER

  • STRONG STAR Consortium

    collaborator UNKNOWN

  • Duke University

    lead OTHER

Principal Investigators

  • Patricia A Resick, PhD, ABPP · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02173561 on ClinicalTrials.gov